Company profile for Thea Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Théa creates innovative solutions for better outcomes: developing new approaches to treat eye diseases for which there are currently no treatments, enhancing existing ocular treatments by improving efficacy, simplifying existing procedures, or improving safety by reducing side effects. Our commitment to improving lives is borne of our pioneering spirit: we continue to lead the worldwide preservative-free movement in eye care...
Théa creates innovative solutions for better outcomes: developing new approaches to treat eye diseases for which there are currently no treatments, enhancing existing ocular treatments by improving efficacy, simplifying existing procedures, or improving safety by reducing side effects. Our commitment to improving lives is borne of our pioneering spirit: we continue to lead the worldwide preservative-free movement in eye care. We’ve created innovative delivery systems. We’re fixated on making products accessible and cost-effective for patients. We live this mission every day because everyone should have the same opportunities

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
420 Bedford Street, Suite 150 Lexington, MA 02420
Telephone
Telephone
781-832-3667
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/thea-pens-280m-deal-iolyxs-phase-3-ready-dry-eye-disease-drug

FIERCE BIOTECH
03 Dec 2025

https://www.businesswire.com/news/home/20250310684433/en

BUSINESSWIRE
10 Mar 2025

https://www.prnewswire.com/news-releases/thea-pharma-inc-launches-iyuzeh-latanoprost-ophthalmic-solution-0-005-in-the-us-301938385.html

PR NEWSWIRE
26 Sep 2023

https://www.prnewswire.com/news-releases/thea-pharma-inc-launches-preservative-freedom-coalition-to-advocate-for-preservative-free-eye-care-301835329.html

PR NEWSWIRE
30 May 2023

https://www.prnewswire.com/news-releases/thea-pharma-inc-statement-related-to-akorns-voluntary-nationwide-recall-of-various-human-and-animal-drug-branded-ophthalmic-products-within-expiry-due-to-company-shutdown-301811331.html

PR NEWSWIRE
28 Apr 2023

https://www.prnewswire.com/news-releases/iyuzeh-latanoprost-ophthalmic-solution-0-005-the-first-and-only-preservative-free-latanoprost-ophthalmic-solution-demonstrated-similar-iop-lowering-efficacy-with-a-favorable-safety-profile-when-compared-to-xalatan-in-patien-301761686.html

PR NEWSWIRE
03 Mar 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty